Cargando…

Use of etanercept for psoriasis in a liver transplant recipient

Detalles Bibliográficos
Autores principales:	Madankumar, Reshmi, Teperman, Lewis W., Stein, Jennifer A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4809584/ https://www.ncbi.nlm.nih.gov/pubmed/27051807 http://dx.doi.org/10.1016/j.jdcr.2015.09.012

Ejemplares similares

Etanercept in the treatment of plaque psoriasis
por: Nguyen, Thao U, et al.
Publicado: (2009)

The safety of etanercept for the treatment of plaque psoriasis
por: Papp, Kim A
Publicado: (2007)

Etanercept in the Treatment of Generalized Annular Pustular Psoriasis
por: Lo Schiavo, Ada, et al.
Publicado: (2012)

Etanercept in psoriasis: the evidence of its therapeutic impact
por: Thomson, Andrew
Publicado: (2007)

Impact of Pretransplant Hepatic Encephalopathy on Liver Posttransplantation Outcomes
por: Teperman, Lewis W.
Publicado: (2013)

Glomerular filtration rate in patients with psoriasis treated with etanercept
por: Gisondi, Paolo, et al.
Publicado: (2016)

Effects of methotrexate and etanercept treatment in moderate and severe psoriasis
por: Benites, Elizabeth, et al.
Publicado: (2022)

Real-World Experience with Etanercept Therapy and the Switching Pattern among Korean Patients with Psoriasis after Withdrawal of Etanercept
por: Choi, Chong Won, et al.
Publicado: (2019)

Paradoxical SAPHO Syndrome after Etanercept in a Patient with Psoriasis
por: Gimeno-Castillo, Javier., et al.
Publicado: (2022)

Etanercept, improved dosage schedules and combinations in the treatment of psoriasis: an update
por: Segaert, Siegfried
Publicado: (2009)

Relationship between etanercept and thyroid function in patients with psoriasis vulgaris
por: ROMAN, IULIA IOANA, et al.
Publicado: (2018)

Treatment of psoriasis with etanercept in immunocompromised patients: Two case reports
por: De Simone, Clara, et al.
Publicado: (2016)

Influence of Donor Race and Donor-recipient Race-matching on Pediatric Kidney Transplant Outcomes
por: Sun, Kennedy, et al.
Publicado: (2022)

Long term efficacy and safety of etanercept in the treatment of psoriasis and psoriatic arthritis
por: Kivelevitch, Dario, et al.
Publicado: (2014)

Long-term safety of etanercept in psoriasis: Retrospective study focused on infections
por: Orsini, Diego, et al.
Publicado: (2016)

Successful Treatment of Inflammatory Linear Verrucous Epidermal Nevus with Concomitant Psoriasis Using Etanercept
por: Saifaldeen, Reda Hesham, et al.
Publicado: (2018)

Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation
por: Chapman, William C., et al.
Publicado: (2017)

Nodular Vasculitis That Developed during Etanercept (Enbrel) Treatment in a Patient with Psoriasis
por: Park, Seung-Bae, et al.
Publicado: (2015)

A cost–utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy
por: Colombo, Giorgio L, et al.
Publicado: (2009)

Orthotopic Liver Transplantation for Etanercept-induced Acute Hepatic Failure: A Case Report
por: Sadeghian, Dorsay, et al.
Publicado: (2020)

Economic Impact of Etanercept in Patients with Psoriasis and Psoriatic Arthritis in Spain: A Systematic Review
por: Puig, Lluís, et al.
Publicado: (2019)

Secondary Generalized Cutaneous Mucinosis Developed During Etanercept Treatment in a Patient with Psoriasis
por: Zhou, Xin, et al.
Publicado: (2022)

Employment is maintained and sick days decreased in psoriasis/psoriatic arthritis patients with etanercept treatment
por: Boggs, Robert L, et al.
Publicado: (2014)

Long-Term Cost-Effectiveness Analysis of Etanercept and Adalimumab for Plaque Psoriasis not Associated with Arthritis
por: Ruano, Juan, et al.
Publicado: (2013)

Steps towards implementation of protocolized dose reduction of adalimumab, etanercept and ustekinumab for psoriasis in daily practice
por: van der Schoot, L.S., et al.
Publicado: (2023)

Acquired latent tuberculosis infection in psoriasis patients treated with etanercept in the People’s Republic of China
por: Li, Cheng-Rang, et al.
Publicado: (2015)

Unmet Personal Patient Needs in Psoriasis Patients with Low Disease Activity on Adalimumab, Etanercept or Ustekinumab
por: van Muijen, Marloes E., et al.
Publicado: (2021)

Diminishing Use of Liver Biopsy among Liver Transplant Recipients for Hepatitis C
por: Aby, Elizabeth, et al.
Publicado: (2017)

Influence of body mass index and weight on etanercept efficacy in patients with psoriasis: A retrospective study
por: Giunta, Alessandro, et al.
Publicado: (2016)

Etanercept ameliorates psoriasis progression through regulating high mobility group box 1 pathway
por: Li, Shu, et al.
Publicado: (2023)

Hyperhomocysteinaemia in liver transplant recipients
por: Nkansa-Dwamema, David, et al.
Publicado: (2004)

Improvements in patient‐reported outcomes in patients with psoriasis receiving etanercept plus topical therapies: results from REFINE
por: Papp, K.A., et al.
Publicado: (2015)

Etanercept biosimilars
por: Azevedo, Valderilio F., et al.
Publicado: (2014)

Critical Care of the Liver Transplant Recipient
por: Fernandez, Thomas M. A., et al.
Publicado: (2015)

Gut microbiota of liver transplantation recipients
por: Sun, Li-Ying, et al.
Publicado: (2017)

Follow-up of liver transplant recipients
por: Neuberger, James
Publicado: (2020)

Postoperative Care of the Liver Transplant Recipient
por: Parekh, Krishna N., et al.
Publicado: (2016)

Elimination of Hepatitis C in Liver Transplant Recipients
por: Saab, Sammy, et al.
Publicado: (2018)

ACUTE APENDICITIS IN LIVER TRANSPLANT RECIPIENTS
por: da FONSECA-NETO, Olival Cirilo Lucena, et al.
Publicado: (2016)

COVID-19 in Liver Transplant Recipients
por: Kullar, Ravina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n473gqmt7tib9l6pu4saa0tnat